Target intelligence / Profile preview

DNABII family DNA-binding protein (DNABII)

Target
DNABII
Molecular classification
DNA-binding protein
01

Overview

The DNABII family DNA-binding protein consists of integration host factor (IHF) and histone-like protein (HU), which are highly conserved bacterial proteins that bind DNA as dimers and condense it, playing essential roles in nucleoid structure and extracellular matrix stability. In bacterial biofilms, these proteins localize at vertices of the extracellular DNA (eDNA) lattice, stabilizing the interwoven web-like structure critical for biofilm integrity across pathogens like uropathogenic Escherichia coli (UPEC), nontypeable Haemophilus influenzae (NTHI), and Staphylococcus epidermidis. This stabilization protects bacteria from antibiotics and host immune responses, contributing to chronic and recurrent infections such as urinary tract infections, otitis media, and cystic fibrosis exacerbations. DNABII proteins exhibit high affinity for branched DNA structures like Holliday junctions, enabling them to act as lynchpins in the biofilm matrix. Targeting DNABII proteins with antibodies or inhibitors disrupts biofilm formation, promotes dispersal, and increases bacterial susceptibility to conventional antibiotics, positioning them as promising therapeutic targets for biofilm-mediated diseases. Experimental depletion of DNABII via anti-IHF antibodies reduces biofilm biomass and mechanical rigidity, while functional replacement with other Holliday junction-binding proteins like RuvA confirms their specific structural role.

Other names
integration host factor (IHF)histone-like protein (HU)HU protein
02

Mechanism of action

Disruption of biofilm extracellular matrix via antibody-mediated depletion or inhibitors targeting DNABII proteins to destabilize eDNA lattice and enhance antibiotic susceptibility

03

Biological functions

DNA condensationbiofilm structural stabilizationextracellular DNA lattice organization
04

Disease associations

Infection (biofilm-associated chronic and recurrent infections, urinary tract infections, otitis media, cystic fibrosis)

Beyond the preview

Go deeper on DNABII family DNA-binding protein (DNABII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNABII family DNA-binding protein (DNABII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call